Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-05

FDA Approved: VALSARTAN — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved an Abbreviated New Drug Application for valsartan by Mylan Pharmaceuticals, enabling a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

ORIG AP for VALSARTAN (VALSARTAN)